Rankings
▼
Calendar
BDTX FY 2022 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
BDTX
Black Diamond Therapeutics, Inc.
$126M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$93M
Net Income
-$91M
EPS (Diluted)
$-2.52
Cash Flow
Operating Cash Flow
-$85M
Free Cash Flow
-$85M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$156M
Total Liabilities
$41M
Stockholders' Equity
$116M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$93M
-$127M
+26.8%
Net Income
-$91M
-$126M
+27.4%
← Q4 2021
All Quarters
Q1 2022 →